Long-term results of the treatment of Hodgkin’s lymphoma in a resource-constrained setting: Real-world data from a single center

The outcomes of Hodgkin´s lymphoma (HL) in México have not been widely reported. Simplified and affordable treatments have been adopted in middle-income countries.The aim was to evaluate long-used therapies for HL in México in a long-term basis.In a 34-year time period, 88 patients with HL were treated at a single institution in México. Patients were treated with adriamycin bleomycin vinblastine and dacarbazine (ABVD) or mechlorethamine,...